A breast cancer diagnosis is overwhelming. In the weeks after hearing those words, you'll face a cascade of medical appointments, treatment decisions, and — whether you want to or not — urgent medical aid questions. This article addresses the most important financial and coverage questions directly, so you can focus on your care.
First, a Note on Tone
This article is not going to minimise what you're facing. Breast cancer is serious. But your medical aid situation — if handled proactively — does not need to be an additional source of crisis. Many people navigate this well. The key is knowing what to ask and when.
Does My Medical Aid Have to Cover This?
Yes. Breast cancer is covered under the Prescribed Minimum Benefits (PMB) — which means your medical aid is legally required to fund your diagnosis and treatment, regardless of your plan option or waiting periods. The scheme cannot decline to cover breast cancer.
What the PMB does NOT guarantee: - Full payment of specialist fees (they may pay at tariff, which is less than what your doctor charges) - Funding for newer medicines like CDK4/6 inhibitors (these typically require exceptional-needs authorisation) - Coverage without prior authorisation (get authorisation for everything)
The First Call You Should Make
Before your next specialist appointment, call your medical aid case management line (not the general call centre — ask for oncology case management). Tell them:
- You have been diagnosed with breast cancer.
- You need to register for your PMB oncology benefit.
- Ask for a dedicated case manager to be assigned to your treatment journey.
A case manager will coordinate pre-authorisations, liaise with your oncologist, and help ensure your claims are correctly classified as PMB. This one call can prevent a large proportion of disputed claims later.
What Is My Oncology Sub-Limit?
Your plan documents (or your scheme's app) will list an oncology benefit — typically a rand amount per year. This is the maximum your scheme will pay for cancer treatment in a 12-month period. Common ranges in the SA market:
- Hospital plan / basic plan: R100,000–R200,000 (often insufficient for systemic treatment)
- Mid-tier: R250,000–R400,000
- Comprehensive: R500,000–R800,000
- Executive/unlimited oncology plans: No rand cap
Find this number now. If your treatment plan is expected to cost more than your sub-limit (your oncologist can give you a rough projection), you need a plan. This may mean:
- Applying to move to a higher-benefit option (within the same scheme, options can change without a new waiting period — confirm with your scheme)
- Assessing whether gap cover is still available to you (some gap cover products have late-stage application restrictions; check your specific product)
Do I Need Gap Cover?
If you don't have gap cover, understand what this means: specialist fees in SA oncology are frequently charged at 200–400% of medical aid tariff. Your medical aid pays at 100% of its own tariff. You pay the difference.
On a course of chemotherapy infusions, this gap can amount to R5,000–R15,000 per infusion visit. Over a treatment year, total specialist shortfalls can reach R80,000–R200,000.
Gap cover policies pay these shortfalls, up to an Overall Payment Limit (OPL) of approximately R220,000 per year. This is not unlimited protection — in a complex metastatic case, the OPL may be reached before your treatment year ends. But having gap cover is vastly better than not having it.
If you do not have gap cover and your diagnosis is new, speak to a financial advisor immediately. Some gap products can still be applied for in early treatment; others have closed windows. Act quickly.
What Medicines Are Covered?
Your medical aid must fund the PMB-minimum treatment for your cancer subtype. In broad terms:
- ER+/PR+ (hormone receptor-positive): Tamoxifen, aromatase inhibitors — generally funded, low cost.
- HER2+: Trastuzumab (Herceptin) — generally funded as PMB; monthly cost ~R25,000–R30,000.
- CDK4/6 inhibitor (palbociclib, ribociclib): Usually NOT PMB — your oncologist must submit an exceptional-needs motivation. Approval is not guaranteed, but many schemes do approve with a strong motivation.
- Triple-negative: Chemotherapy protocols are PMB; immunotherapy (pembrolizumab) is usually exceptional-needs.
If your oncologist recommends a medicine and your scheme declines it, you have the right to: 1. Request formal written reasons for the refusal. 2. Submit an internal appeal through your scheme. 3. Escalate to the Council for Medical Schemes (CMS) complaints process.
Do not accept a verbal decline without a written response. The PMB regulations give you real legal standing to challenge inappropriate refusals.
The Next Three Months: A Practical Checklist
| Action | Why |
|---|---|
| Register with oncology case management | Prevents claims falling through administrative gaps |
| Get a written treatment plan from your oncologist | Essential for prior authorisation and exceptional-needs motivations |
| Confirm your oncology sub-limit and remaining benefit | Know your ceiling before you begin treatment |
| Check your gap cover status and OPL | Understand your shortfall protection |
| Ask your oncologist about the Designated Service Provider (DSP) | Using in-network facilities reduces out-of-pocket costs |
| Contact CANSA (0800 22 6622) | Free counselling, support groups, and patient navigation assistance |
| Consider a financial advisor review of your cover | Especially if your sub-limit appears inadequate for your treatment plan |
Will I Be Able to Change My Plan?
Intra-scheme option changes (moving to a higher plan within the same medical aid) are generally available and cannot result in new waiting periods for an existing condition. If your current plan's oncology sub-limit is insufficient, escalate to the highest available option within your scheme before your treatment year starts.
Moving to a new scheme after a cancer diagnosis is substantially more complex. Open enrolment periods have conditions, and pre-existing condition waiting periods apply. Do not cancel your existing scheme in the expectation of moving to another one without advice.
Support Resources
CANSA (Cancer Association of South Africa): 0800 22 6622 (toll-free) | www.cansa.org.za Support groups, counselling, patient navigation, practical assistance
Pink Drive: www.pinkdrive.co.za Breast health services, support for breast cancer patients
Talk to Eldon
Get help understanding your plan options →
This page is general information about medical schemes. It is not medical advice: speak to a healthcare professional about your own treatment. Medical aid and gap cover advice is given by Eldon de Waal, a Supervised Representative of Approach Administration (FSP 23579).